SV1997000068A - Variantes de aprotinina con propiedades mejoradas ref. lea 31764-sv - Google Patents

Variantes de aprotinina con propiedades mejoradas ref. lea 31764-sv

Info

Publication number
SV1997000068A
SV1997000068A SV1997000068A SV1997000068A SV1997000068A SV 1997000068 A SV1997000068 A SV 1997000068A SV 1997000068 A SV1997000068 A SV 1997000068A SV 1997000068 A SV1997000068 A SV 1997000068A SV 1997000068 A SV1997000068 A SV 1997000068A
Authority
SV
El Salvador
Prior art keywords
read
improved properties
aprotinin
aprotinin variants
ref
Prior art date
Application number
SV1997000068A
Other languages
English (en)
Inventor
Werner Schroder
Soren Bjorn
Kjeld Norris
Viggio Diness
Leif Norkskov-Lauritsen
Niels Dyhr Christensen
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of SV1997000068A publication Critical patent/SV1997000068A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8114—Kunitz type inhibitors
    • C07K14/8117—Bovine/basic pancreatic trypsin inhibitor (BPTI, aprotinin)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8114—Kunitz type inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A VARIANTES DE APROTININA CON PROPIEDADES INHIBITORIAS DE ENZIMAS INMUNOLOGICAS Y FARMACOCINETICAS MEJORADAS Y A SU PRODUCCION.LA APROTININA SE COMPONE DE 58 AMINOACIDOS. LA ESTRUCTURA TRIDIMENSIONAL DE LA PROTEINA SE ELUCIDO CON AUXILIO DE ANALISIS ESTRUCTURAL POR RAYOS X Y ESPECTROS COPIA RMN.
SV1997000068A 1996-07-25 1997-07-21 Variantes de aprotinina con propiedades mejoradas ref. lea 31764-sv SV1997000068A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19629982A DE19629982A1 (de) 1996-07-25 1996-07-25 Aprotinin-Varianten mit verbesserten Eigenschaften

Publications (1)

Publication Number Publication Date
SV1997000068A true SV1997000068A (es) 1998-07-09

Family

ID=7800774

Family Applications (1)

Application Number Title Priority Date Filing Date
SV1997000068A SV1997000068A (es) 1996-07-25 1997-07-21 Variantes de aprotinina con propiedades mejoradas ref. lea 31764-sv

Country Status (37)

Country Link
US (2) US6482798B2 (es)
EP (1) EP0821007B1 (es)
JP (1) JPH10101700A (es)
KR (1) KR980009283A (es)
CN (1) CN1172116A (es)
AR (1) AR008783A1 (es)
AT (1) ATE260975T1 (es)
AU (2) AU2870197A (es)
BG (1) BG101787A (es)
BR (1) BR9704068A (es)
CA (1) CA2207071A1 (es)
CO (1) CO4890857A1 (es)
CZ (1) CZ236797A3 (es)
DE (2) DE19629982A1 (es)
DZ (1) DZ2276A1 (es)
EE (1) EE9700177A (es)
ES (1) ES2217350T3 (es)
HN (1) HN1997000094A (es)
HR (1) HRP970384A2 (es)
HU (1) HUP9701290A3 (es)
ID (1) ID17508A (es)
IL (1) IL121361A0 (es)
MA (1) MA24279A1 (es)
NO (1) NO973426L (es)
NZ (1) NZ328402A (es)
PE (1) PE92298A1 (es)
PL (1) PL321341A1 (es)
RU (1) RU2197983C2 (es)
SG (1) SG71714A1 (es)
SK (1) SK101997A3 (es)
SV (1) SV1997000068A (es)
TN (1) TNSN97130A1 (es)
TR (1) TR199700688A2 (es)
TW (1) TW480271B (es)
UA (1) UA55380C2 (es)
YU (1) YU31697A (es)
ZA (1) ZA976585B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19725014A1 (de) * 1997-06-13 1998-12-17 Bayer Ag Aprotininvarianten mit verbesserten Eigenschaften und Bikunine von Aprotininvarianten
US6974188B2 (en) * 2003-08-13 2005-12-13 Cosco Management, Inc. Chair with pivotable chair back
WO2006042327A2 (en) * 2004-10-12 2006-04-20 Large Scale Biology Corporation Plant-produced recombinant aprotinin and aprotinin variants
US20060218667A1 (en) * 2004-10-12 2006-09-28 Vojdani Fakhrieh S Plant-produced recombinant aprotinin and aprotinin variants
ES2383901T5 (es) * 2005-02-18 2015-02-25 Angiochem Inc. Polipéptidos de aprotinina para transportar un compuesto a través de la barrera sangre-cerebro
WO2008077478A1 (en) * 2006-12-22 2008-07-03 Bayer Schering Pharma Aktiengesellschaft Preparation and use of variants of the kunitz domain 2 of the human placental bikunin gene
WO2008110301A1 (de) * 2007-03-13 2008-09-18 Bayer Schering Pharma Aktiengesellschaft Aprotinin-varianten mit verbesserten eigenschaften
DE102007056231A1 (de) 2007-09-08 2009-03-12 Bayer Healthcare Ag Herstellung und Verwendung von Varianten humander Kunitz-Typ Protease-Inhibitoren (hKTPI)
BRPI1103921A2 (pt) 2011-08-17 2013-08-06 Mahle Metal Leve Sa camisa de cilindro e liga de ferro fundido

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU560584B2 (en) * 1983-07-28 1987-04-09 Bayer Aktiengesellschaft Homologues of aprotinin
US4595974A (en) * 1984-09-10 1986-06-17 Burroughs Corporation Base drive circuit for a switching power transistor
GB2208511A (en) 1987-08-07 1989-04-05 Bayer Ag Variants of bovine pancreatic trypsin inhibitor produced by recombinant dna technology
US5591603A (en) * 1987-08-28 1997-01-07 Novo Nordisk A/S Process for preparing aprotinin and aprotinin analogs in yeast cells
DK225488D0 (da) * 1988-04-26 1988-04-26 Novo Industri As Polypeptid
DK463887D0 (da) 1987-09-07 1987-09-07 Novo Industri As Gaerleader
DK105489D0 (da) 1989-03-03 1989-03-03 Novo Nordisk As Polypeptid
DE3930522A1 (de) * 1989-09-13 1991-03-21 Bayer Ag Rekombinante aprotinin-varianten - gentechnisches verfahren zur mikrobiellen herstellung von homogen prozessierten aprotinin-varianten sowie die therapeutische anwendung derselben
US5231010A (en) 1989-09-13 1993-07-27 Bayer Aktiengesellschaft Recombinant aprotinin variants genetically engineered process for the microbial preparation of homogeneously processed aprotinin variants and the therapeutic use thereof
IL99585A0 (en) * 1990-10-01 1992-08-18 Novo Nordisk As Aprotinin analogues,their production and pharmaceutical compositions containing them
JPH07509229A (ja) * 1992-07-13 1995-10-12 コルバス・インターナショナル、インコーポレイテッド ウシ膵トリプシン阻害因子から誘導される因子Ｘａの阻害因子
KR100199565B1 (ko) * 1994-08-19 1999-06-15 차동천 승화형 감열전사 기록용 수용지의 중간층 제조방법

Also Published As

Publication number Publication date
HN1997000094A (es) 1997-12-26
CZ236797A3 (cs) 1998-02-18
PL321341A1 (en) 1998-02-02
NO973426D0 (no) 1997-07-24
TNSN97130A1 (fr) 2005-03-15
SG71714A1 (en) 2000-04-18
MX9705605A (es) 1998-08-30
BR9704068A (pt) 1999-01-05
MA24279A1 (fr) 1998-04-01
ATE260975T1 (de) 2004-03-15
YU31697A (sh) 1999-07-28
PE92298A1 (es) 1999-02-13
CN1172116A (zh) 1998-02-04
DE59711356D1 (de) 2004-04-08
HRP970384A2 (en) 1998-04-30
US20030096752A1 (en) 2003-05-22
EP0821007B1 (de) 2004-03-03
AU762041B2 (en) 2003-06-19
NZ328402A (en) 1999-03-29
HUP9701290A3 (en) 2000-08-28
IL121361A0 (en) 1998-01-04
US20020103334A1 (en) 2002-08-01
KR980009283A (ko) 1998-04-30
BG101787A (en) 1998-10-30
US6482798B2 (en) 2002-11-19
TW480271B (en) 2002-03-21
UA55380C2 (uk) 2003-04-15
ES2217350T3 (es) 2004-11-01
EP0821007A3 (de) 1998-11-18
TR199700688A2 (xx) 1998-02-21
CO4890857A1 (es) 2000-02-28
DE19629982A1 (de) 1998-01-29
DZ2276A1 (fr) 2002-12-18
CA2207071A1 (en) 1998-01-25
EP0821007A2 (de) 1998-01-28
ID17508A (id) 1998-01-08
AR008783A1 (es) 2000-02-23
RU2197983C2 (ru) 2003-02-10
ZA976585B (en) 1998-02-03
SK101997A3 (en) 1998-03-04
AU5178701A (en) 2001-09-06
NO973426L (no) 1998-01-26
HU9701290D0 (en) 1997-09-29
JPH10101700A (ja) 1998-04-21
EE9700177A (et) 1998-02-16
HUP9701290A2 (hu) 1999-06-28
AU2870197A (en) 1998-02-05

Similar Documents

Publication Publication Date Title
Nyirkos et al. Human synovial cells secrete a 39 kDa protein similar to a bovine mammary protein expressed during the non-lactating period
DE69332879D1 (de) Technetium-99-markierte peptide zur visualisierung vom entzuendungen
ATE152918T1 (de) Technetium-99m-markierte peptide zur bilderzeugung
FI932561A0 (fi) Proteiner med foeraendrade epitoper och foerfaranden foer deras framstaellning
BE879733A (fr) Procede de production d'une preparation de facteur antihemophilique et preparation ainsi obtenue
FR2499414B1 (fr) Production d'anticorps proteiniques humains
SV1997000068A (es) Variantes de aprotinina con propiedades mejoradas ref. lea 31764-sv
PT90413A (pt) Processo de producao de dispersoes de polissacarideo/proteina microfragmentadas e anisotropicas
DE69434729D1 (de) TECHNETIUM-99m MARKIERTE PEPTIDE ZUR DIAGNOSTISCHEN BILDERZEUGUNG VON ENTZÜNDUNGEN
FI920764A0 (fi) Fusionsproteiner omfattande gm-csf och il-3.
ATE323511T1 (de) Technetium-99m markierte peptide zur bildformung
ATE212059T1 (de) Methoden zur identifizierung heterofunktionaler fusionsproteine
ES2013328A6 (es) Un metodo para detectar anticuerpos contra antigenos hiv-1.
BR9105179A (pt) Composicao e processo de producao de boroidreto de sodio compactado
KR950702242A (ko) 사포린 함유 단백질의 재조합 생산방법(Recombinant production of saporin-containing proteins)
DE69317886D1 (de) Neue propoxyphenderivate sowie deren protein-und polypeptidlabels und-konjugate
AU5008785A (en) Process for synthesising peptides
ES2150443T3 (es) Derivados de benzodiazepina y conjugados proteicos y polipeptidicos de los indicados derivados.
YU73494A (sh) Postupak za dobijanje proteina
DK0406598T3 (da) Proteinhydrolyse
ATE141415T1 (de) Konjugate von antikörpern mit variablen domänen
DE69611037D1 (de) Methadonderivate und protein- und polypeptid-methadonkonjugate und markierte verbindungen
NO20020329L (no) Antitumor-antistoffer, proteiner og anvendelse derav
IT1240365B (it) Procedimento di produzione di fibra sintetica e di fibra vegetale mediante proteina di fibroina
DK75393D0 (da) Production of protein